Clinical Trial Update: Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006) [Phase 1]

View source ↗

Summary

Phase 1 study of Frespaciguat (MK-5475) in participants with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD) has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Frespaciguat

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2024-04-26